License: Creative Commons Attribution 4.0 PDF - Published Version (569kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-568724
- DOI to cite this document:
- 10.5283/epub.56872
Abstract
Purpose Due to thromboembolic complications and in-stent-stenosis after flow diverter (FD) treatment, the long-term use of dual antiplatelet treatment (DAPT) is mandatory. The tested nano-coating has been shown to reduce material thrombogenicity and promote endothelial cell proliferation in vitro. We compared the biocompatibility of coated (Derivo Heal) and non-coated (Derivo bare) FDs with DAPT ...
Owner only: item control page